Breaking News

Celerion To Support FNIH Biomarkers Consortium

June 11, 2014

Will provide clinical services to support The Beta Cell Project

Celerion has been selected by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium to provide clinical support for The Beta Cell Project, a program of studies designed to standardize biomarker measures of beta cell function. Celerion will provide clinical services to support the development of pharmacodynamic measures with the goal of creating industry standards.
 
The Biomarkers Consortium is a public-private biomedical research partnership managed by the FNIH aims to discover, develop, and qualify biomarkers to support drug development, preventive medicine, and medical diagnostics. 
 
“Celerion has continued to invest in and expand our capabilities in metabolic disease to support early Proof-of-Concept studies in the development of diabetes, obesity, metabolic and cardio-metabolic interventions. We are therefore delighted to have been selected to support programs by the FNIH in the area of metabolic disorders,” said Philip Bach, vice president of Global Clinical Research at Celerion. “The award of this program, and knowing that our contribution will help set industry standards, is recognition of our expertise in this area and the quality of data delivered to clients.”
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Successful Method Transfer of Solid Oral Dosage

    Successful Method Transfer of Solid Oral Dosage

    John Frankonis, Ropack Pharma Solutions||June 2, 2016
    The three steps outlined will help guide the process of completing a successful analytical method transfer